[SINGAPORE] The following companies saw new developments that may affect trading of their securities on Wednesday (Jan 14):
Keppel Real Estate Investment Trust (Reit) : The trust on Tuesday said that it has received valid acceptances of 76.9 per cent at the close of its preferential offering announced on Dec 11, 2025. It received valid acceptances for 709.4 million units, out of the 923.2 million units on offer. It received excess applications of 185.7 million units, or 20.1 per cent of the total number of units available under the preferential offering. The new units will be listed on the Singapore Exchange from 9 am on Jan 19. Units of Keppel Reit closed flat at S$0.985 on Tuesday.
Olam Group : The food producer on Wednesday said the proposed sale of its remaining 32.4 per cent stake in Arise P&L, set to be completed by Dec 31, 2025, is still undergoing. The board said it has “made progress” in securing approvals from different lenders to Arise P&L, upon which the sale was contingent. It said it “intends to proceed to complete the proposed disposal as soon as practicable” once all approvals are received. Shares of Olam rose 0.5 per cent to close S$0.005 higher at S$0.94 on Tuesday.
Frasers and Neave (F&N) : The beverage maker on Tuesday priced S$125 million in fixed-rate notes due Jan 20, 2033, at 2.6 per cent per annum. The notes, to be issued by wholly owned subsidiary F&N Treasury, are part of the company’s S$2 billion multicurrency debt issuance programme. They will be issued on Jan 20, 2026, and are guaranteed by F&N. Shares of F&N closed flat at S$1.50 on Tuesday.
Centurion : The property manager on Tuesday said the development and divestment of Epiisod Macquarie Park under a forward purchase agreement have taken place. The vendor, Lachlan Avenue Development, is 25 per cent owned by Centurion Corporation and 75 per cent owned by Centurion Properties. Wholly owned subsidiary Centurion Australia Management has been appointed to provide property management services. Shares of Centurion rose 0.7 per cent to close S$0.10 higher at S$1.37 on Tuesday.
Cordlife : The company announced on Wednesday a one-year renewal of its cord blood banking service license from Jan 14, 2026, to Jan 13, 2027. The company also announced that it has applied to convert ongoing client claims to an “originating claim”, with claimants due to respond by Feb 3. Shares of Cordlife fell 2.3 per cent to close S$0.003 lower at S$0.127 on Tuesday.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.

